BAPTIST CLINICAL RESEARCH INSTITUTE INC (EIN 453032246) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2011

Legal Domicile

Principal Officer

GARY C ANDERSON

Phone

9012275336

Tax Period

2023-10-01 to 2024-09-30

BAPTIST CLINICAL RESEARCH INSTITUTE INC, founded in 2011, is a community nonprofit in the Science & Technology sector that reported $2.2M in total revenue in fiscal year 2023. Expenses of $4.3M exceeded revenue, resulting in a 99% operating deficit.

Mission

BAPTIST CLINICAL RESEARCH INSTITUTE, INC. PERFORMS AND FACILITATES MEDICAL AND SCIENTIFIC RESEARCH AND EDUCATIONAL ACTIVITIES.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $249,559

Program Service Revenue $1,911,079

Investment Income $0

Other Revenue $0

TOTAL REVENUE $2,160,638

Expense Breakdown

Grants Paid $0

Salaries & Benefits $3,573,498

Fundraising Expenses $0

Program Expenses $3,853,698

Other Expenses $725,678

TOTAL EXPENSES $4,299,176

Year-over-Year Comparison

	2023	2022	Change
Revenue	$2,160,638	$2,161,067	0.0%
Expenses	$4,299,176	$4,263,925	+0.0%
Net Income	$-2,138,538	$-2,102,858	+0.0%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

N/A

Employees

Volunteers

N/A

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$2,796,880

Total Directors

$8,072,383

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
WILLIAM A GRIFFIN	DIRECTOR (THRU 10/23)	0.04	Director	$0	$66,668	$1,381,083
GREGORY M DUCKETT	SECRETARY/DIRECTOR	0.04	Officer Director	$0	$90,318	$1,346,501
GARY C ANDERSON	DIRECTOR (THRU 12/23)/PRESIDENT	0.04	Officer Director	$0	$88,606	$1,300,745
MARK E SWANSON MD	DIRECTOR	0.04	Director	$0	$24,823	$1,220,645
PHILIP LAMMERS MD	DIRECTOR	0.04	Director	$0	$58,215	$1,164,577
KIMBERLY O YOUNG	DIRECTOR (AS OF 11/23)	0.04	Director	$0	$47,942	$620,481
JUSTIN RHODES	DIRECTOR (AS OF 09/24)	0.04	Director	$0	$84,677	$526,012
WILLIAM CLOUD MD	DIRECTOR (AS OF 09/24)	0.04	Director	$0	$56,774	$512,339
ROPO O SANVEE	CFO	3.00	Officer	$0	$33,094	$149,634
ALEXANDER R QUESENBERRY	DIR.-PHARM. INFUSION CENTER/RESEARCH	20.00	Highest	$86,055	$62,844	$230,667
PAUL KOROS	DIRECTOR-CLINICAL RESEARCH	40.00	Highest	$151,915	$40,225	$192,140
GLENN ROMA	PHARMACIST-INVESTIGATIONAL	40.00	Highest	$115,961	$37,721	$153,682
TRACY B STEWART	ASSISTANT DIRECTOR-RESEARCH	40.00	Highest	$116,379	$34,347	$150,726
HUIBO SHAO	SCIENTIST-RESEARCH III	40.00	Highest	$131,106	$85	$131,191
PAUL D DEPRIEST MD	FORMER PRESIDENT	0.00		$0	$85,100	$2,156,966
MARGARET DEBON	FORMER EXEC. DIRECTOR-DEV. RES.	0.00		$145,405	$5,084	$150,489

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$2,160,638	$4,299,176	$400,714	$-2,138,538
2023	$2,161,067	$4,263,925	$455,611	$-2,102,858
2022	$1,800,525	$4,347,213	$507,696	$-2,546,688
2021	$1,977,517	$3,957,317	$153,363	$-1,979,800
2020	$1,729,642	$3,213,146	$138,519	$-1,483,504
2019	$2,016,558	$3,490,797	$130,843	$-1,474,239
2018	$1,194,241	$2,996,206	$241,554	$-1,801,965

BAPTIST CLINICAL RESEARCH INSTITUTE INC